Santen Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Santen Pharmaceutical Co. Ltd.
MFS International Value Fund
19,575,300
4.8%
0
1%
07/31/2018
MFS Research International Fund
6,777,000
1.67%
291,500
1.23%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
5,984,500
1.47%
95,000
0.13%
07/31/2018
Vanguard Total International Stock Index Fund
5,158,244
1.27%
70,600
0.02%
07/31/2018
Black Creek Global Leaders Fund
4,735,020
1.15%
4,735,020
3.8%
06/30/2017
Schroder ISF - Japanese Equity
3,892,400
0.96%
-68,600
2.17%
05/31/2018
Schroder UTL - Tokyo Fund
3,680,000
0.9%
-121,300
1.67%
05/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
2,937,500
0.72%
70,000
0.13%
07/31/2018
Government Pension Fund - Global (The)
2,830,500
0.7%
-1,260,200
0.01%
12/31/2017
Nikko Asset Listed Index TOPIX ETF (1308)
2,695,400
0.66%
0
0.13%
08/20/2018
| Address |
Grand Front Osaka Tower A, 25/F
Osaka Osaka 530
Japan
|
|
Employees
|
- |
| Website |
http://www.santen.co.jp |
| Updated |
07/08/2019 |
| Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. |
